Induction_NN
of_IN
activator_NN
protein_NN
-LRB-_-LRB-
AP_NN
-RRB-_-RRB-
-1_CD
and_CC
nuclear_JJ
factor-kappaB_NN
by_IN
CD28_NN
stimulation_NN
involves_VBZ
both_CC
phosphatidylinositol_NN
3-kinase_NN
and_CC
acidic_JJ
sphingomyelinase_NN
signals_NNS
._.

A_DT
major_JJ
obstacle_NN
in_IN
understanding_VBG
the_DT
signaling_VBG
events_NNS
that_WDT
follow_VBP
CD28_NN
receptor_NN
ligation_NN
arises_VBZ
from_IN
the_DT
fact_NN
that_IN
CD28_NN
acts_VBZ
as_IN
a_DT
costimulus_NN
to_TO
TCR_NN
engagement_NN
,_,
making_VBG
it_PRP
difficult_JJ
to_TO
assess_VB
the_DT
relative_JJ
contribution_NN
of_IN
CD28_NN
signals_NNS
as_IN
distinct_JJ
from_IN
those_DT
of_IN
the_DT
TCR_NN
._.

To_TO
overcome_VB
this_DT
problem_NN
,_,
we_PRP
have_VBP
exploited_VBN
the_DT
observation_NN
that_IN
activated_VBN
human_JJ
T_NN
cell_NN
blasts_NNS
can_MD
be_VB
stimulated_VBN
via_IN
the_DT
CD28_NN
surface_NN
molecule_NN
in_IN
the_DT
absence_NN
of_IN
antigenic_JJ
challenge_NN
;_:
thus_RB
,_,
we_PRP
have_VBP
been_VBN
able_JJ
to_TO
observe_VB
the_DT
response_NN
of_IN
normal_JJ
T_NN
cells_NNS
to_TO
CD28_NN
activation_NN
in_IN
isolation_NN
._.

Using_VBG
this_DT
system_NN
,_,
we_PRP
observed_VBD
that_IN
CD28_NN
stimulation_NN
by_IN
B7-transfected_JJ
CHO_NN
cells_NNS
induced_VBD
a_DT
proliferative_JJ
response_NN
in_IN
T_NN
cells_NNS
that_WDT
was_VBD
not_RB
accompanied_VBN
by_IN
measurable_JJ
IL-2_NN
production_NN
._.

However_RB
,_,
subsequent_JJ
analysis_NN
of_IN
transcription_NN
factor_NN
generation_NN
revealed_VBD
that_IN
B7_NN
stimulation_NN
induced_VBD
both_CC
activator_NN
protein-1_NN
-LRB-_-LRB-
AP-1_NN
-RRB-_-RRB-
and_CC
nuclear_JJ
factor-kappaB_NN
-LRB-_-LRB-
NF-kappaB_NN
-RRB-_-RRB-
complexes_NNS
,_,
but_CC
not_RB
NF-AT_NN
._.

In_IN
contrast_NN
,_,
engagement_NN
of_IN
the_DT
TCR_NN
by_IN
class_NN
II_CD
MHC\/superantigen_NN
,_,
either_CC
with_IN
or_CC
without_IN
CD28_NN
ligation_NN
,_,
resulted_VBD
in_IN
the_DT
induction_NN
of_IN
NF-AT_NN
,_,
AP-1_NN
,_,
and_CC
NF-kappaB_NN
as_RB
well_RB
as_IN
IL-2_NN
production_NN
._.

Using_VBG
selective_JJ
inhibitors_NNS
,_,
we_PRP
investigated_VBD
the_DT
signaling_VBG
pathways_NNS
involved_VBN
in_IN
the_DT
CD28-mediated_JJ
induction_NN
of_IN
AP-1_NN
and_CC
NF-kappaB_NN
._.

This_DT
revealed_VBD
that_IN
NF-kappaB_NN
generation_NN
was_VBD
sensitive_JJ
to_TO
chloroquine_NN
,_,
an_DT
inhibitor_NN
of_IN
acidic_JJ
sphingomyelinase_NN
,_,
but_CC
not_RB
to_TO
the_DT
phosphatidylinositol_NN
3-kinase_NN
inhibitor_NN
,_,
wortmannin_NN
._.

In_IN
contrast_NN
,_,
AP-1_NN
generation_NN
was_VBD
inhibited_VBN
by_IN
wortmannin_NN
and_CC
was_VBD
also_RB
variably_RB
sensitive_JJ
to_TO
chloroquine_NN
._.

These_DT
data_NNS
suggest_VBP
that_IN
in_IN
activated_VBN
normal_JJ
T_NN
cells_NNS
,_,
CD28-derived_JJ
signals_NNS
can_MD
stimulate_VB
proliferation_NN
at_IN
least_JJS
in_IN
part_NN
via_IN
NF-kappaB_NN
and_CC
AP-1_NN
generation_NN
,_,
and_CC
that_IN
this_DT
response_NN
uses_VBZ
both_CC
acidic_JJ
sphingomyelinase_NN
and_CC
phosphatidylinositol_NN
3-kinase-linked_JJ
pathways_NNS
._.

